Company Overview and News

 
Renaissance Gold Drilling Update

2018-05-01 accesswire
VANCOUVER, BC / ACCESSWIRE / May 1, 2018 / Renaissance Gold Inc. TSX.V: REN ("RenGold" or the "Company") expects exploration drilling programs on at least seven of its partner-funded projects during 2018. Some of that drilling is ongoing and other programs are planned for later in the year. The following is an update on two of these projects already underway.

 
Westgold buys S2 Resources’ Polar Bear project in WA

2018-02-14 australianmining.com.au
Westgold Resources has secured a deal to acquire S2 Resources’ (S2) interests in the Polar Bear project, Eundynie joint venture and Norcott project in Western Australia in exchange for $9 million in shares of S2 subsidiary Polar Metals. S2 has 100, 80, and 100 per cent interests in the three projects, respectively.

 
S2 sells Polar Bear to Westgold

2018-02-13 businessnews.com.au
Mark Bennett’s S2 Resources has sold the Polar Bear gold project to Westgold in a $9 million partially scrip deal.

 
Argonaut Resources planning to drill this week

2017-09-25 proactiveinvestors.com.au
Argonaut Resources (ASX:ARE) plans to commence initial drilling on two gold prospects at its Higginsville Project located in Western Australia this Friday 29 September 2017.

 
Renaissance Gold - Building Strong Platform for Success

2017-08-10 accesswire
VANCOUVER, BC / ACCESSWIRE / August 10, 2017 / Renaissance Gold Inc. (TSX-V: REN) ("RenGold" or the "Company") is pleased to summarize a number of significant positive developments over the past several months, which collectively define a transformational event for the Company. In the past three months, the Company has executed new deals on eight Nevada properties, completed the significant corporate acquisition of Kinetic Gold Corp.

 
S2 Resources moving into explore the gold riches of Nevada, U.S.

2017-08-01 proactiveinvestors.com.au
S2 Resources (ASX:S2R) has signed an agreement with Renaissance Gold Inc (TSE:REN) to earn a 70% interest in three gold exploration properties situated on major mineralised trends in Nevada, U.S.

 
Renaissance Gold Executes Earn-in Agreement with S2 Resources Ltd. to Fund Three Projects in Nevada

2017-07-31 accesswire
VANCOUVER, BC / ACCESSWIRE / July 31, 2017 / Renaissance Gold Inc. (TSX-V: REN) ("RenGold" or the "Company") is pleased to announce that its wholly owned subsidiary, Kinetic Gold (US) Inc. has signed a definitive agreement with S2 Resources Ltd. (ASX: S2R) through its subsidiary Nevada Star Resources LLC. The agreement grants S2 the option to acquire a 70% interest in the South Roberts, Pluto and Ecru projects located in Nevada.

 
Dowling, Boyle join Fleetwood

2017-03-22 businessnews.com.au
S2 Resources chairman Jeff Dowling and Clayton Utz partner Stephen Boyle have been named incoming directors of Fleetwood Corporation, while Michael Hardy has retired from board.

 
S2 Resources to reveal update

2017-02-09 proactiveinvestors.com.au
S2 Resources (ASX:S2R) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.

 
Proactive Investors partnering with Mines and Money Australia

2016-10-26 proactiveinvestors.com.au
Mines and Money Australia is free for investors to attend. To apply for your free investor pass, click here: http://imarcmelbourne.com/investors/ To download the full programme, click here: http://imarcmelbourne.com/download-programme/ Mines and Money Australia is the country's largest mining investment forum held during the International Mining and Resources Conference (IMARC). IMARC will take place from Monday, 7th to Thursday, 10th November 2016 at the Melbourne Convention & Exhibition Centre.

 
The Bullish Case For Aussie Gold

2016-09-19 seekingalpha
On Thursday of last week, I arrived back in the States after spending two weeks globetrotting and attending international investing conferences, first in New Orleans, then in Lima, Peru.

 
Legend Mining Ltd's investment yields significant cash

2016-08-08 proactiveinvestors.com.au
Legend Mining Ltd's (ASX:LEG) exploration focus is on its nickel-copper Fraser Range Project in Western Australia, while also actively seeking new project opportunities.

 
Australia's tiny miners rise from the ashes of the bust

2016-08-03 reuters
SYDNEY From gold to graphite to zinc to lithium, Australia's army of "penny dreadful" stocks is rising from the ashes of the mining bust and growing at rates that majors like BHP Billiton and Rio Tinto can only wish for.

 
ASX ekes out small gain in 'patchwork' day

2016-07-26 theage.com.au
Shares posted a small gain on Tuesday despite spending most of the day in the red, dragged by weakness in energy stocks and a retreat from Woolworths after its blockbuster Monday.

 
ASX ekes out small gain in 'patchwork' day

2016-07-26 smh.com.au
Shares posted a small gain on Tuesday despite spending most of the day in the red, dragged by weakness in energy stocks and a retreat from Woolworths after its blockbuster Monday.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...